Russian Rosnano, jointly with the American venture Fund Domain Associates and pharmaceutical company Pfizer, starts the construction of a factory for the production of drugs in the Kaluga region in Russia.
These plans were unveiled by the head of Rosnano, Anatoly Chubais, at an opening ceremony of a new technology center titled “Novamediki”.
We should remind you that Rosnano was established by the government of Russia for the purpose of commercializing developments in nanotechnology.
“In late May, Rosnano, jointly with Domain and Pfizer, will launch the construction of this unique center, a production site, from which we want to grow a big Russian pharmaceutical enterprise”, he said.
The facility in the Kaluga region will carry out mass production of drugs that will be developed in the running “Novamediki” technology center.